Madrigal Pharmaceuticals, Inc. Common Stock
Symbol: MDGL (NASDAQ)
435.20
▲ (1.18%) 5.090
Company Description:
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
Key Stats
- Today's Open: $435.2
- Today's High: $435.2
- Today's Low: $435.2
- Today's Volume: 322
- Yesterday Close: $430.11
- Yesterday High: $450.225
- Yesterday Low: $429.62
- Yesterday Volume: 281.69K
- Last Min Volume: 135
- Last Min High: $435.2
- Last Min Low: $435.2
- Last Min VWAP: $435.2
Company Profile
- Name: Madrigal Pharmaceuticals, Inc. Common Stock
- Website: https://www.madrigalpharma.com
- Listed Date: 2007-02-06
- Location: WEST CONSHOHOCKEN, PA
- Market Status: Active
- CIK Number: 0001157601
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.59B
- Round Lot: 100
- Outstanding Shares: 22.29M
- Asset Type: CS
RECENT FILINGS FOR MDGL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 144 | View |
| 2025-09-09 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-21 | 4 | View |
| 2025-08-21 | 144 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 144 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 144 | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 144 | View |
| 2025-08-12 | 144 | View |
Latest News on MDGL